Last updated: 2026-09-23 02:00:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Pfizer Inc. (PFE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $27,92, with a market capitalisation of $157,65B and a P/E ratio of 36,50. Over the past 52 weeks, its price has ranged from $23,58 to $29,21. This page covers its latest market performance, valuation, price trends and company information.
$157,65B | |
$27,74 | |
$61,71 | |
$11,62 | |
$27,74 | |
21,57M | |
40,63M | |
36,50 | |
$29,21 | |
$23,58 | |
6,19% | |
-- |
Pfizer Inc. (PFE) last closed at $27,74 as of 2026-09-22 23:58:27, unchanged from the previous close of $27,74.
During the latest regular trading session, PFE traded between $11,62 and $61,71, with a volume of 21,57M shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Pfizer Inc. (PFE) moved from $27,72 to $27,92, representing a gain of 0,73% ($0,20).
The stock traded between $27,25 and $28,19 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 36,28 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 77,1%
PFE is currently trading at $27,92, placing it 77,1% of the way from its 52-week low of $23,58 to its 52-week high of $29,21. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 75000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Pfizer Inc. (PFE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.